Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 3 | 2019 | 22 | 0.720 |
Why?
|
| Obesity, Morbid | 2 | 2019 | 29 | 0.570 |
Why?
|
| Weight Loss | 2 | 2019 | 138 | 0.430 |
Why?
|
| Macular Degeneration | 1 | 2013 | 30 | 0.390 |
Why?
|
| Vitamin K | 1 | 2012 | 9 | 0.380 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 15 | 0.370 |
Why?
|
| Warfarin | 1 | 2012 | 66 | 0.350 |
Why?
|
| Anticoagulants | 1 | 2012 | 121 | 0.340 |
Why?
|
| Aging | 1 | 2013 | 764 | 0.270 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 90 | 0.180 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 47 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2015 | 14 | 0.140 |
Why?
|
| Middle Aged | 6 | 2019 | 11819 | 0.140 |
Why?
|
| Protein Multimerization | 2 | 2015 | 114 | 0.140 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2015 | 13 | 0.120 |
Why?
|
| Plant Proteins | 1 | 2015 | 100 | 0.110 |
Why?
|
| Vibrio | 1 | 2014 | 18 | 0.110 |
Why?
|
| Leptospira | 1 | 2014 | 27 | 0.110 |
Why?
|
| Vitreous Body | 1 | 2013 | 11 | 0.100 |
Why?
|
| Retinaldehyde | 1 | 2013 | 15 | 0.100 |
Why?
|
| Injections | 1 | 2013 | 40 | 0.100 |
Why?
|
| Receptors, Adrenergic | 4 | 1979 | 11 | 0.100 |
Why?
|
| Female | 6 | 2019 | 24018 | 0.100 |
Why?
|
| Vitamins | 1 | 2013 | 81 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 233 | 0.100 |
Why?
|
| Visual Acuity | 1 | 2013 | 117 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 1979 | 35 | 0.100 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 10 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 180 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 30 | 0.090 |
Why?
|
| Zinc | 1 | 2013 | 130 | 0.090 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2011 | 3 | 0.090 |
Why?
|
| Aminoglycosides | 1 | 2011 | 6 | 0.090 |
Why?
|
| Serum Albumin | 1 | 2012 | 58 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2011 | 20 | 0.090 |
Why?
|
| Drug Resistance | 1 | 2012 | 97 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 358 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2013 | 208 | 0.090 |
Why?
|
| Comorbidity | 1 | 2013 | 725 | 0.090 |
Why?
|
| Life Style | 1 | 2013 | 326 | 0.090 |
Why?
|
| Obesity | 1 | 2018 | 1131 | 0.080 |
Why?
|
| Male | 8 | 2019 | 22779 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 580 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 916 | 0.080 |
Why?
|
| Humans | 7 | 2019 | 42163 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 415 | 0.070 |
Why?
|
| Aged | 3 | 2019 | 7982 | 0.070 |
Why?
|
| Adult | 4 | 2019 | 13458 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2013 | 2485 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 2803 | 0.060 |
Why?
|
| Risk Factors | 1 | 2013 | 3942 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 285 | 0.050 |
Why?
|
| Arabidopsis | 2 | 2015 | 102 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 491 | 0.050 |
Why?
|
| United States | 1 | 2013 | 5072 | 0.050 |
Why?
|
| Adolescent | 1 | 2013 | 5950 | 0.050 |
Why?
|
| Dextroamphetamine | 2 | 1979 | 9 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2015 | 875 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 73 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 9 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 33 | 0.040 |
Why?
|
| Calibration | 1 | 2018 | 62 | 0.040 |
Why?
|
| Simvastatin | 1 | 2018 | 29 | 0.040 |
Why?
|
| Cholesterol | 1 | 2019 | 230 | 0.030 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1977 | 15 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2018 | 164 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 230 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 458 | 0.030 |
Why?
|
| Phloem | 1 | 2015 | 2 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1020 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 70 | 0.030 |
Why?
|
| Brain | 3 | 1979 | 1452 | 0.030 |
Why?
|
| Arabidopsis Proteins | 1 | 2015 | 45 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 185 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 201 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1058 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1574 | 0.030 |
Why?
|
| Movement | 1 | 2014 | 116 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2014 | 420 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 242 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 299 | 0.020 |
Why?
|
| Alprenolol | 3 | 1978 | 3 | 0.020 |
Why?
|
| Pharmacists | 1 | 2011 | 56 | 0.020 |
Why?
|
| Rubidium | 1 | 1978 | 6 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 1978 | 25 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1266 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1977 | 10 | 0.020 |
Why?
|
| Heart | 1 | 1977 | 181 | 0.010 |
Why?
|
| Rats | 4 | 1979 | 3701 | 0.010 |
Why?
|
| Microsomes | 2 | 1977 | 55 | 0.010 |
Why?
|
| Kinetics | 2 | 1979 | 698 | 0.010 |
Why?
|
| Doxepin | 1 | 1977 | 1 | 0.010 |
Why?
|
| Iprindole | 1 | 1977 | 1 | 0.010 |
Why?
|
| Desipramine | 1 | 1977 | 13 | 0.010 |
Why?
|
| Animals | 5 | 1979 | 16695 | 0.010 |
Why?
|
| Cocaine | 1 | 1979 | 248 | 0.010 |
Why?
|
| Ouabain | 1 | 1978 | 15 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1978 | 26 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1978 | 27 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1978 | 17 | 0.000 |
Why?
|
| Triiodothyronine | 1 | 1977 | 36 | 0.000 |
Why?
|
| Melanoma | 1 | 1978 | 109 | 0.000 |
Why?
|
| Binding Sites | 1 | 1977 | 670 | 0.000 |
Why?
|
| Myocardium | 1 | 1977 | 251 | 0.000 |
Why?
|
| Dihydroalprenolol | 1 | 1979 | 6 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1979 | 110 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1979 | 135 | 0.000 |
Why?
|
| Mice | 1 | 1978 | 6490 | 0.000 |
Why?
|